Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF
Holding CRDF?
Track your performance easily

Cardiff Oncology (CRDF) Technical Analysis

1,483 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Cardiff Oncology, Inc.’s (CRDF) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Cardiff Oncology, Inc. is a Sell.
Cardiff Oncology, Inc.’s (CRDF) 20-Day exponential moving average is 2.40, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.585, making it a Buy.
Cardiff Oncology, Inc.’s (CRDF) 50-Day exponential moving average is 2.44, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.585, making it a Buy.

Cardiff Oncology (CRDF) Pivot Points

Sep 20, 2024, 06:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.13
2.28
2.37
2.51
2.60
2.75
2.84
Fibonacci
2.28
2.37
2.42
2.51
2.60
2.66
2.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cardiff Oncology (CRDF) Moving Averages

Sep 20, 2024, 06:24 PM
Period
Simple
Exponential
MA5
2.56Sell
2.51Buy
MA10
2.44Buy
2.46Buy
MA20
2.36Buy
2.40Buy
MA50
2.34Buy
2.44Buy
MA100
2.69Sell
2.60Sell
MA200
2.79Sell
2.44Buy
Cardiff Oncology, Inc.’s (CRDF) 10-Day exponential moving average is 2.46, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.585, making it a Buy.
Cardiff Oncology, Inc.’s (CRDF) 100-Day exponential moving average is 2.60, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.585, making it a Sell.
Cardiff Oncology, Inc.’s (CRDF) stock price is $2.585 and Cardiff Oncology, Inc.’s (CRDF) 50-day simple moving average is 2.34, creating a Buy signal.
Cardiff Oncology, Inc.’s (CRDF) stock price is $2.585 and Cardiff Oncology, Inc.’s (CRDF) 100-day simple moving average is 2.69, creating a Sell signal.
Cardiff Oncology, Inc.’s (CRDF) stock price is $2.585 and Cardiff Oncology, Inc.’s (CRDF) 200-day simple moving average is 2.79, creating a Sell signal.

Cardiff Oncology (CRDF) Technical Indicators

Sep 20, 2024, 06:24 PM
Name
Value
Implied Action
RSI (14)
56.63
Neutral
STOCH (9,6)
57.27
Neutral
STOCHRSI (14)
57.93
Neutral
MACD (12,26)
0.06
Sell
ADX (14)
19.97
Buy
Williams %R
-39.31
Buy
CCI (14)
104.35
Sell
ATR (14)
0.18
-
Ultimate Oscillator
47.79
Neutral
ROC
10.00
Buy
Cardiff Oncology, Inc.’s (CRDF) Relative Strength Index (RSI) is 56.63, creating a Neutral signal.
Cardiff Oncology, Inc.’s (CRDF) Trend Strength Indicator (ADX) is 19.97, creating a Buy signal.
Cardiff Oncology, Inc.’s (CRDF) Commodity Channel Index (CCI) is 104.35, creating a Sell signal.
Cardiff Oncology, Inc.’s (CRDF) Price Rate of Change (ROC) is 10.00, creating a Buy signal.

FAQ

Is CRDF a Buy, Hold, or Sell?
Based on CRDF’s technical indicators, CRDF is a Buy.
    What is CRDF’s RSI (14)?
    CRDF’s RSI (14) is 56.63, which suggests CRDF is a Neutral.
      What is CRDF’s MACD?
      CRDF’s MACD is 0.06, which suggests CRDF is a Sell.
        What is CRDF’s 5-day moving average?
        CRDF’s 5-day moving average is 2.56, which suggests CRDF is a Sell.
          What is CRDF’s 20-day moving average?
          CRDF 20-day moving average is 2.36, which suggests CRDF is a Buy.
            What is CRDF’s 50-day moving average?
            CRDF’s 50-day moving average is 2.34, which suggests CRDF is a Buy.
              What is CRDF’s 200-day moving average?
              CRDF’s 200-day moving average is 2.79, which suggests CRDF is a Sell.
                What is CRDF’s Williams % R (14)?
                CRDF’s Williams % R (14) is -39.31, which suggests CRDF is a Buy.
                  What is CRDF’s CCI (14)?
                  CRDF’s CCI (14) is 104.35, which suggests CRDF is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis